迪馬股份(600565.SH):香港聯交所上市委員會已審閲東原仁知服務的上市申請
格隆匯3月28日丨 迪馬股份(600565.SH)公佈,公司收到控股子公司東原仁知城市運營服務集團股份有限公司(“東原仁知服務”)通知,香港聯交所上市委員會於2022年3月24日舉行上市聆訊,審議東原仁知服務首次公開發行境外上市外資股(H股)並在香港聯交所主板上市的申請。東原仁知服務H股保薦人已於3月25日收到香港聯交所向其發出的信函,當中指出香港聯交所上市委員會已審閲東原仁知服務的上市申請,但該信函並不構成正式的上市批准,香港聯交所仍有對東原仁知服務的上市申請提出進一步意見的權力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.